Metrika

  • citati u SCIndeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[]
  • posete u poslednjih 30 dana:0
  • preuzimanja u poslednjih 30 dana:0

Sadržaj

članak: 2 od 26  
Back povratak na rezultate
2021, vol. 78, br. 2, str. 236-244
Imunizacija kod inflamatornih bolesti creva - preporuke za primenu vakcina
aVojnomedicinska akademija, Klinika za gastroenterologiju i hepatologiju, Beograd
bVojnomedicinska akademija, Klinika za gastroenterologiju i hepatologiju, Beograd + Univerzitet odbrane, Medicinski fakultet Vojnomedicinske akademije, Beograd

e-adresapericsasa@ymail.com
Sažetak
Članak ne sadrži sažetak.
Reference
*** (1993) Recommendations of the Advisory Committee on Immunization Practices (ACIP): Use of vaccines and immune globulins for persons with altered immunocompetence. MMWR Recomm Rep, 42(RR-4): 1-18
Aberra, F.N., Lichtenstein, G.R. (2005) Methods to avoid infections in patients with inflammatory bowel disease. Inflamm Bowel Dis, 11(7): 685-695
Abu-Shakra, M., Press, J., Varsano, N., Levy, V., Mendelson, E., Sukenik, S., et al. (2002) Specific antibody response after influenza immunization in systemic lupus erythematosus. Am J Phys Med Rehabil, 29(12): 2555-7
Baldassano, R.N., Bradfield, J.P., Monos, D.S., Kim, C.E., Glessner, J.T., Casalunovo, T., Frackelton, E.C., Otieno, F. G., Kanterakis, S., Shaner, J.L., Smith, R.M., Eckert, A.W., Robinson, L.J. (2007) Association of variants of the interleukin-23 receptor gene with susceptibility to pediatric Crohn's disease. Clin Gastroenterol Hepatol, 5(8): 972-976
Baron, S., Turck, D., Leplat, C., Merle, V., Gower-Rousseau, C., Marti, R., et al. (2005) Environmental risk factors in paediatric inflammatory bowel diseases: A population based case control study. Gut, 54(3): 357-363
Bhatia, J., Bratcher, J., Korelitz, B., Vakher, K., Mannor, S., Shevchuk, M., et al. (2006) Abnormalities of uterine cervix in women with inflammatory bowel disease. World J Gastroenterol, 12(38): 6167-71
Cheent, K., Nolan, J., Shariq, S., Kiho, L., Pal, A., Arnold, J. (2010) Case report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease. J Crohns Colitis, 4(5): 603-605
Chevaux, J., Nani, A., Oussalah, A., Venard, V., Bensenane, M., Belle, A., Gueant, J., Bigard, M., Bronowicki, J., Peyrin-Biroulet, L. (2010) Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France. Inflamm Bowel Dis, 16(6): 916-924
Deutsch, D.E., Olson, A.D., Kraker, S., Dickinson, C.J. (1995) Overwhelming varicella pneumonia in a patient with Crohn's disease treated with 6-mercaptopurine. J Pediatr Gastroenterol Nutr, 20(3): 351-353
Dezfoli, S., Melmed, G.Y. (2012) Vaccination issues in patients with inflammatory bowel disease receiving immunosuppression. Gastroenterol Hepatol, NY, 8(8): 504-12
Dotan, I., Werner, L., Vigodman, S., Agarwal, S., Pfeffer, J., Horowitz, N., Malter, L., Abreu, M., Ullman, T., Guzner-Gur, H., Halpern, Z., Mayer, L. (2012) Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines. Inflamm Bowel Dis, 18(2): 261-268
Elkayam, O., Ablin, J., Caspi, D. (2007) Safety and efficacy of vaccination against streptococcus pneumonia in patients with rheumatic diseases. Autoimmun Rev, 6(5): 312-314
Gilat, T., Hacohen, D., Lilos, P., Langman, M.J.S. (1987) Childhood factors in ulcerative colitis and Crohn's disease: An international cooperative study. Scand J Gastroenterol, 22(8): 1009-1024
Gisbert, J.P., Chaparro, M. (2013) Vaccination strategies in patients with IBD. Nat Rev Gastroenterol Hepatol, 10(5): 277-285
Hugot, J., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J., Belaiche, J., Almer, S., Tysk, C., O'Morain, C.A., Gassull, M., Binder, V., Finkel, Y., Cortot, A., Modigliani, R., Laurent-Puig, P. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature, 411(6837): 599-603
Jarrett, M.P., Schiffman, G., Barland, P., Grayzel, A.I. (1980) Impaired response to pneumococcal vaccine in systemic lupus erythematosus. Arthritis Rheum, 23(11): 1287-1293
Kane, S., Khatibi, B., Reddy, D. (2008) Higher incidence of abnormal pap smears in women with inflammatory bowel disease. Am J Gastroenterol, 103(3): 631-636
Korelitz, B.I., Fuller, S.R., Warman, J.I., Goldberg, M.D. (1999) Shingles during the course of treatment with 6-mercaptopurine for inflammatory bowel disease. Am J Gastroenterol, 94(2): 424-426
Leigh, R.J., Turnberg, L.A. (1980) BCG vaccination and Crohn's disease. Dig Dis Sci, 25(12): 972
Lu, Y., Jacobson, D., Bousvaros, A. (2009) Immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis, 15(9): 1417-1423
Melmed, G.Y. (2009) Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics. Inflamm Bowel Dis, 15(9): 1410-1416
Melmed, G.Y., Ippoliti, A.F., Papadakis, K.A., Tran, T.T., Birt, J.L., Lee, S.K., Frenck, R.W., Targan, S.R., Vasiliauskas, E.A. (2006) Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol, 101(8): 1834-1840
Nguyen, G.C., Kaplan, G.G., Harris, M.L., Brant, S.R. (2008) A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol, 103(6): 1443-1450
Nies, K., Boyer, R., Stevens, R., Louie, J. (1980) Anti-tetanus toxoid antibody synthesis after booster immunization in systemic lupus erythematosus: Comparison of the in vitro and in vivo responses. Arthritis Rheum, 23(12): 1343-50
Rahier, J.F., Magro, F., Abreu, C., Armuzzi, A., Ben-Horin, S., Chowers, Y., Cottone, M., de Ridder, L., Doherty, G., Ehehalt, R., Esteve, M., Katsanos, K., Lees, C.W., Macmahon, E., Moreels, T., Reinisch, W., Tilg, H., Tremblay, L., Veereman-Wauters, G., Viget, N. (2014) Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis, 8(6): 443-468
Reich, J., Wasan, S., Farraye, F.A. (2016) Vaccinating patients with inflammatory bowel disease. Gastroenterol Hepatol, NY, 12(9): 540-546
Sempere, L., Almenta, I., Barrenengoa, J., Gutiérrez, A., Villanueva, C.O., de-Madaria Enrique,, García, V., Sánchez-Payá, J. (2013) Factors predicting response to hepatitis B vaccination in patients with inflammatory bowel disease. Vaccine, 31(30): 3065-3071
Symmers, W.S. (1965) Opportunistic infections: The concept of opportunistic infections. Proc R Soc Med, 58(5): 341-6
Tamas, E., Mannor, S., Shevchuk, M. (2002) Cervical squamous lesions associated with ulcerative colitis. Mod Pathol, 15: 212A
Viget, N., Vernier-Massouille, G., Salmon-Ceron, D., Yazdanpanah, Y., Colombel, J.-F. (2008) Opportunistic infections in patients with inflammatory bowel disease: Prevention and diagnosis. Gut, 57(4): 549-558
Villumsen, M., Jess, T., Sørup, S., Ravn, H., Sturegård, E., Benn, C.S., et al. (2013) Risk of inflammatory bowel disease following Bacille Calmette-Guérin and smallpox vaccination: A population-based Danish case-cohort study. Inflamm Bowel Dis, 19(8): 1717-24
 

O članku

jezik rada: engleski
vrsta rada: stručni članak
DOI: 10.2298/VSP190423055P
primljen: 23.04.2019.
revidiran: 16.05.2019.
prihvaćen: 16.05.2019.
objavljen onlajn: 17.05.2019.
objavljen u SCIndeksu: 12.03.2021.
metod recenzije: dvostruko anoniman
Creative Commons License 4.0

Povezani članci

Nema povezanih članaka